VAERS Reports U006489

VAERS 2214110

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

schwer

Staat: NJ
Alter: 15,0
Geschlecht: M
Eingang: 04.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Head injury Neurological examination Syncope

Symptomtext

A few minutes after receiving vaccines, approx 8:10pm, the pt fainted and fell in the exam room. The fall was witnessed by the pt's aunt. Per pt's aunt, the pt "got up from the table, fainted, fell and hit his head on the floor." When the nurse arrived to the room, the pt was laying on the floor with the aunt rubbing his head. Pt opened his eyes. The doctor was immediately called to the room and vital signs were taken. Pt denied pain and dizziness. Pt slowly got up from the floor and was able to sit on the table. Pt denied nausea, dizziness, and pain. The doctor assessed the pt and completed a neuro exam. The doctor advised the aunt to take the pt to the ER if pt c/o h/a, n/v, blurry vision. Pt stayed in waiting area for observation before leaving. Upon leaving, pt states he is feeling better. He continues to deny pain, dizziness, and nausea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None reported.
Vorgeschichte: None reported.
Andere Medikamente: NA
Allergien: No known allergies.
Vorherige Impfungen: -

VAERS 2171062

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

schwer

Staat: FL
Alter: 4,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 01.03.2022
Beginn: 03.03.2022
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Febrile convulsion

Symptomtext

Febrile Seizure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Febrile convulsion
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Level 1 (Autism) Language disorder, mixed receptive-expressive Myringotomy tubes status
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2269067

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

mild

Staat: NC
Alter: 1,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 21.04.2022
Beginn: 07.05.2022
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: SC / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rash

Symptomtext

Onset 5/7/22 of widespread rash. Started with spots on thighs and then spread all over body. No treatment needed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: diagnosed with Covid-19 on 4/26/22
Vorgeschichte: None
Andere Medikamente: Augmentin started on 4/26/22 for otitis Cefdinir started on 5/2/22 for pneumonia
Allergien: none known
Vorherige Impfungen: -

VAERS 2236124

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

mild

Staat: MI
Alter: 1,6
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Pyrexia

Symptomtext

(No Adverse Events )I talked to Mother on 04/14/2022 to inform her that an extra dose of MMR had been Administered to her child Mother reported that She is Doing fine, She had a Slight Fever of 100'c that measured with thermometer ,gave her some tylenol an has been doing fine she was given the shots we discussed just keeping an eye on her an call us back if she has any concerns.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2187605

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

mild

Staat: FL
Alter: 5,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Culture throat Headache Streptococcus test negative Tonsillar erythema Tonsillar hypertrophy Urticaria

Symptomtext

She developed a slight cough and slight headache on 3/17/22. She went to daycare today (3/18/22)and developed hives on her legs and neck. No known exposure to any food allergens. Her tonsils are red and swollen, she was tested for strep; the rapid strep is negative and throat culture is pending.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: Atopic dermatitis, history of Kawasaki disease diagnosed February 2020
Andere Medikamente: Zyrtec
Allergien: Dairy, eggs,peanuts ,soy and wheat
Vorherige Impfungen: -

VAERS 2632104

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: SD
Alter: 1,0
Geschlecht: F
Eingang: 15.05.2023
Impfdatum: 19.10.2022
Beginn: 23.01.2023
Tage bis Beginn: 96,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Interchange of vaccine products No adverse event Product administered to patient of inappropriate age

Symptomtext

Denies side effects or symptoms / no additional AE; 1st dose with MMR II and Varivax and 2nd dose with Proquad; PROQUAD second dose prior to age of 4-6 years of age.; This spontaneous report was received from a nurse and refers to a 15-month-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-OCT-2022 (at 12 months old), the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin) (M-M-R II) injection, lot #U006489, expiration date reported and confirmed upon internal validation as 26-FEB-2023 (exact dose, frequency, route and site of administration were not reported), and on the same day, she was vaccinated individually with the first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, lot #U039722, expiration date reported and confirmed upon internal validation as 15-DEC-2023 (exact dose, route and site of administration were not reported), both for prophylaxis. On 23-JAN-2023 (at 15 months old), the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant human albumin) (PROQUAD) injection, lot #W028564, expiration date reported and confirmed upon internal validation as 06-MAR-2024 (exact dose, frequency, route and site of administration were not reported) as second dose, also for prophylaxis (interchange of vaccine products, product administered to patient of inappropriate age). Side effects or symptoms were denied (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Interchange of vaccine products
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599382

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u006489

gering

Staat: AZ
Alter: -
Geschlecht: U
Eingang: 20.03.2023
Impfdatum: 27.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs were reported,; Pharmacy tech called and reported that an expired MMR II vaccine was given to a patient.; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 27-FEB-2023, the patient was vaccinated with an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, lot #u006489, expiration date: 26-FEB-2023, therapy type: rHA, administered for prophylaxis (dose, strength and route of administration were not provided) (expired product administered). No additional adverse events (AEs) were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599144

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CO
Alter: 53,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 27.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported.; expired MMR II was administered to a patient.; This spontaneous report as received from a medical assistant refers to a 53 year old female patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 27-FEB-2023, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) subcutaneous Injection (therapy type: recombinant Human albumin (rHA) (0.5 milliliter, lot # U006489, expiration date 26-FEB-2023, route was not reported) for prophylaxis (expired product administered). No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590564

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CO
Alter: 52,0
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: 27.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; expired MMR II was administered to a patient; This spontaneous report was received from a medical assistant referring to a 52-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 27-FEB-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) subcutaneous injection (quantity: 1, 0.5 ml, lot#: U006489, expiration date: 26-FEB-2023; route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590564

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CO
Alter: 52,0
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: 27.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; expired MMR II was administered to a patient; This spontaneous report was received from a medical assistant referring to a 52-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 27-FEB-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) subcutaneous injection (quantity: 1, 0.5 ml, lot#: U006489, expiration date: 26-FEB-2023; route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2592667

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 08.03.2023
Impfdatum: 03.03.2023
Beginn: 03.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No other adverse events reported; Caller reports that a patient was administered an expired MMR II today.; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, drugs reactions or allergies and concomitant medications were not provided. On 03-MAR-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rha) (M-M-R II) subcutaneous injection (valid lot number U006489 with an expiration date on 26-FEB-2023) (dose, route of administration, strength, frequency, and anatomical injection site were not provided) for prophylaxis (expired product administered), and sterile diluent (STERILE DILUENT) (valid lot number W010864 with an expiration date on 23-OCT-2024 or valid lot number W010871 with an expiration date on 17-NOV-2024 [conflicting information both lot number were reported, the reporter was unsure which was used]). No other adverse events reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: STERILE DILUENT
Allergien: -
Vorherige Impfungen: -

VAERS 2590563

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 27.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Patient did not have a reaction. Expired vaccination was administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2484022

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: WA
Alter: 4,0
Geschlecht: M
Eingang: 20.10.2022
Impfdatum: 18.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event

Symptomtext

Injection given IM instead of SC. Child tolerated immunization well, no adverse reactions have been reported to date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: unknown
Vorgeschichte: none reported
Andere Medikamente: unknown
Allergien: none known
Vorherige Impfungen: -

VAERS 2466380

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 01.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

Healthcare business professional is reporting the administration of improperly stored vaccines; No additional AE reported.; This spontaneous report was received from an office manager regarding to an unknown number of patients of unspecified age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported On unknown dates, the patients were vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human Albumin (rHA) (M-M-R II) lot #U017524, expiration date reported as 26-FEB-2023 but upon internal review established as 03-JUN-2023 and lot #U006489, expiration date reported as 03-JUN-2023 but upon internal review established as 26-FEB-2023 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis; and/or varicella virus vaccine live (oka/merck) (VARIVAX) lot #U019904, expiration date: 24-JUN-2023 and lot #U039948, expiration date: 16-DEC-2022 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis (Product storage error). The improperly stored doses underwent a temperature excursion (temperature was not provided) for an unknown time frame. No adverse events were reported. This is a non-valid report due to lack of patient's identifiers. Follow-up information has been received from an office manager on 14-SEP-2022 concerning a 5-year-old female patient. On 30-AUG-2022, the vaccines measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human Albumin (rHA) (M-M-R II) (lot# U017524) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot# U039948) were administered subcutaneously on left deltoid (LD) and right deltoid (RD) respectively. The patient had one previous dose of each vaccine (unknown dates of administration). This case was previously considered non-valid but per follow-up information it was determined to be valid as patient's details were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2460769

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u006489

gering

Staat: DE
Alter: 47,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

Patient assessed for requested vaccines. MMR requested per immunization requirements. She had not had an MMR and it had been required. A Varicella vaccine had been administered by a pharmacy on 9/20/2022. Since Varicella and MMR are both live vaccines, they should have been given 4 weeks apart. The patient did not have any adverse effects, but vaccines was not given per recommendations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2276437

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: CA
Alter: 5,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 13.05.2022
Beginn: 13.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event Wrong product administered

Symptomtext

MMR vaccine given (patient had already received 2 doses required) instead of Varicella vaccine (2nd dose due) at time of visit. No symptoms during visit. Patient monitored 30 minutes after vaccination. Varicella vaccine not given during visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2867773

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: MA
Alter: 2,3
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 22.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Wrong product administered

Symptomtext

Pt was accidently given two doses of DTAP on 4/22/22. She was supposed to receive Hep A, Pentacel, PCV13, MMR, Varicella. CDC state vaccine unit & Regional Imm nurse notified. Parent was notified and advised what s/s to look for and advised to f/u with our office for any side effects / concerns.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none known
Vorgeschichte: none
Andere Medikamente: none
Allergien: NKA
Vorherige Impfungen: -

VAERS 2151653

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: NY
Alter: 35,0
Geschlecht: F
Eingang: 02.03.2022
Impfdatum: 22.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

The Menactra(meningococcal) vaccine that the patient received was 4 days past its expiration date. Writer called Sanofi Pasteur to verify if there was any flexibility in regards to the expiration date and they stated there was not and that it was advised to re-administer a nonexpired dose of the vaccine and there was no need to delay the readministration. We called the patient 2 days later when we realized the vaccine was expired and she was able to return for readministration of Menactra.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1892610

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006489

gering

Staat: NY
Alter: -
Geschlecht: U
Eingang: 23.11.2021
Impfdatum: 30.10.2021
Beginn: 30.10.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

No other AE or PQC reported; Improperly Stored Administered Vaccine; This spontaneous repot was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 30-OCT-2021, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant Human albumin)(M-M-R II) lot # U006489 was confirmed to be valid, expiration date 26-FEB-2023, 1 time dose for prophylaxis (exact dose, route and site of administration were not reported). The administered dose was exposed to the temperature of 20 degrees Celsius (C) for 168 hours. There was no previous temperature excursion. No signs or symptoms were reported. No additional adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -